This fast track antibody is not yet fully characterized. It is subject to these terms and conditions

Overview

Properties

Target

  • Involvement in diseaseNote=A chromosomal aberration involving AFF1 is associated with acute leukemias. Translocation t(4;11)(q21;q23) with MLL/HRX. The result is a rogue activator protein.
  • Sequence similaritiesBelongs to the AF4 family.
  • Cellular localizationNucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • AF 4 antibody
    • AF 4 protein antibody
    • AF4 antibody
    • AF4-MLL antibody
    • AF4/FMR2 family member 1 antibody
    • AFF 1 antibody
    • AFF1 antibody
    • AFF1_HUMAN antibody
    • ALL1 fused gene from chromosome 4 antibody
    • ALL1-fused gene from chromosome 4 protein antibody
    • FEL antibody
    • MGC134969 antibody
    • MLL/AF4 antibody
    • MLLT2 antibody
    • myeloid/lymphoid or mixed lineage leukemia (trithorax homolog, Drosophila); translocated to, 2 antibody
    • MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA TRANSLOCATED TO 2; MLLT2 antibody
    • PBM1 antibody
    • Pre B cell monocytic leukemia partner 1 antibody
    • Protein AF-4 antibody
    • Protein FEL antibody
    • Proto-oncogene AF4 antibody
    see all

References for Anti-AF4 antibody (ab31812)

This product has been referenced in:
  • Ahmad K  et al. Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL. Oncogenesis 3:e127 (2014). ChIP . Read more (PubMed: 25402609) »
  • Wilkinson AC  et al. RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. Cell Rep 3:116-27 (2013). WB, ChIP, CHIPseq ; Human . Read more (PubMed: 23352661) »

See all 4 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab31812.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"